Want to join the conversation?
$ALXN's net product sales for FY15 grew by 17% from last year. The increase was primarily due to rise in unit volumes of 29% due to increased demand globally for Soliris therapy for patients with PNH or aHUS during the respective periods. The positive impact of volume on net product sales was offset by negative impact on foreign exchange of 8%.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!